Possible adverse effects of drugs used in refractive surgery

Journal of Cataract and Refractive Surgery

Volumn 29, Issue 1, 2003, Pages 170-175

  Fraunfelder, Frederick W ^a,b,c   Rich, Larry F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c or 97239 4197   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; APRACLONIDINE; ARTIFICIAL TEAR; ATROPINE; BENZODIAZEPINE DERIVATIVE; BRIMONIDINE; CIPROFLOXACIN; CYCLOPENTOLATE; CYCLOPLEGIC AGENT; DICLOFENAC; ERYTHROMYCIN; GENTAMICIN; HOMATROPINE; KETOROLAC TROMETAMOL; LOTEPREDNOL ETABONATE; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PHENYLEPHRINE; POVIDONE IODINE; PREDNISOLONE ACETATE; PROXYMETACAINE; SCOPOLAMINE; STEROID; TETRACAINE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TROPICAMIDE;

ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; APLASTIC ANEMIA; BLEPHAROSPASM; BRAIN PSEUDOTUMOR; CONJUNCTIVITIS; CONTACT DERMATITIS; CORNEA SURGERY; DISORIENTATION; DOSE RESPONSE; DRUG INFORMATION; DRUG LABELING; DRUG SAFETY; EYE IRRITATION; EYE SURGERY; EYE TOXICITY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HEART ARREST; HUMAN; HYPERACTIVITY; KERATITIS; MALIGNANT HYPERTENSION; MYASTHENIA; PHOTOPHOBIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; PUNCTATE KERATITIS; REVIEW; SOMNOLENCE; SUBARACHNOID HEMORRHAGE; SYNCOPE; TACHYCARDIA; URTICARIA; VASOMOTOR DISORDER; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

EID: 0037254688     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(02)01836-9     Document Type: Review

References (46)

1. Bettman JW. Seven hundred medicolegal cases in ophthalmology. Ophthalmology 1990; 97:1379-1384
2. Brick DC. Medication errors result in costly claims for ophthalmologists. Surv Ophthalmol 1995; 40:232-236
3. Fraunfelder FT, Fraunfelder FW. Drug-Induced Ocular Side Effects, 5th ed. Boston, MA, Butterworth-Heinemann, 2001
4. Wilson FM. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol 1979; 24:57-88
5. Kortabarria RP, Duran JA, Chacon JR, et al. Toxic psychosis following cycloplegic eyedrops. DICP 1990; 24: 708-709
6. Shihab ZM. Psychotic reaction in an adult after topical cyclopentolate. Ophthalmologica 1980; 181:228-230
7. Newman DK, Jordan K. Generalised urticaria induced by topical cyclopentolate [letter]. Eye 1996; 10:750-751
8. Meyer D, Hamilton RC, Gimbel HV. Myasthenia gravis-like syndrome induced by topical ophthalmic preparations; a case report. J Clin Neuro-Ophthalmol 1992; 12:210-212
9. Meacock DJ, Hewer RL. Tetracycline and benign intracranial hypertension [letter]. Br Med J 1981; 282:1240
10. Chiu AM, Chuenkonqkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126:116-121
11. Shah W, De Cock R. Actinic keratoconjunctivitis and minocycline [letter]. Eye 1999; 13:119-120
12. Fraunfelder FT, Randall JA. Minocycline-induced scleral pigmentation. Ophthalmology 1997; 104:936-938
13. Grant WM. An iodine-vapor applicator for treatment of dendritic keratitis. Arch Ophthalmol 1952; 48:749 -751
14. Tripathi RC, Tripathi BJ. The eye. In: Riddel RH, ed, Pathology of Drug-Induced and Toxic Diseases. New York, NY, Churchill Livingstone, 1982; 405-406
15. Ambrósio Rjr, Wilson SE. Complications of laser in situ keratomileusis: etiology, prevention, and treatment. J Refract Surg 2001; 17:350-379
16. Burns PP. Toxic effects of local anesthetics [letter]. JAMA 1978; 240:347
17. Moreira LB, Kasetsuwan N, Sanchez D, et al. Toxicity of topical anesthetic agents to human keratocytes in vivo. J Cataract Refract Surg 1999; 25:975-980
18. Fraunfelder FT, Meyer SM. Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine [letter]. Am J Ophthalmol 1985; 99:362-363
19. Fraunfelder FW, Fraunfelder FT, Jensvold B. Adverse systemic effects from pledglets of topical ocular phenylephrine 10%. Am J Ophthalmol 2002; 134:624 -625
20. McDonald JE II, El-Moatassem Kotb AM, Decker BB. Effect of brimonidine tartrate ophthalmic solution 0: 2% on pupil size in normal eyes under different luminance conditions. J Cataract Refract Surg 2001; 27:560-564
21. Schuman JS. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol 1996; 41 (suppl 1): S27-S37.
22. Walter KA, Gilbert DD. The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rates in laser in situ keratomileusis patients. Ophthalmology 2001; 108:1434-1438
23. Araujo SV, Bond JB, Wilson RP, et al. Long term effect of apraclonidine. Br J Ophthalmol 1995; 79:1098-1101
24. King MH, Richards DW. Near syncope and chest tightness after administration of apraclonidine before argon laser iridotomy [letter]. Am J Ophthalmol 1990; 110: 308-309
25. GuideraAC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 2001; 108:936-944
26. Hersh PS, Rice BA, Baer JC, et al. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol 1990; 108:577-583
27. Tomas-Barberan S, Fagerholm P. Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy. Acta Ophthalmol Scand 1999; 77:135-138
28. Buckley MMT, Brogden RN. Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990; 39:86-109
29. Sharir M. Exacerbation of asthma by topical diclofenac [letter]. Arch Ophthalmol 1997; 115:294-295
30. Sitenga GL, Ing EB, Van Dellen RG, et al. Asthma caused by topical application of ketorolac. Ophthalmology 1996; 103:90-892
31. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992; 39:259 -284
32. Bettman JW, Aronson SB, Kagawa CM, Hinson DB. The incidence of adverse reactions from steroid/antiinfective combinations. Surv Ophthalmol 1976; 20:281-290
33. Parekh JG, Raviv T, Speaker MG. Grossly false applanation tonometry associated with interface fluid in susceptible LASIK patients [letter]. J Cataract Refract Surg 2001; 27:1143-1144
34. Hamilton DR, Manche EE, Rich LF, Maloney RK. Steroid-induced glaucoma after laser in situ keratomileusis associated with interface fluid. Ophthalmology 2002; 109:659 -665
35. Price FW Jr, Willes L, Price M, et al. A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis. Ophthalmology 2001; 108:1236-1244; discussion by JL Güell, M Vazquez, 1244-1245
36. Essepian JP, Rajpal R, O'Brien TP. Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo. Cornea 1995; 14:402-407
37. Eiferman RA, Snyder JP, Nordquist RE. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. J Cataract Refract Surg 2001; 27: 1701-1702
38. Wilhelmus KR, Hyndiuk RA, Caldwell DR, et al. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis; the Ciprofloxacin Ointment/Bacterial Keratitis Study Group. Arch Ophthalmol 1993; 111:1210-1218
39. Patel GM, Chuang AZ, Kiang E, et al. Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy. J Cataract Refract Surg 2000; 26:690-694
40. Moreira LB, Lee RF, de Oliveira C, et al. Effect of topical fluoroquinolones on corneal reepithelialization after excimer laser keratectomy. J Cataract Refract Surg 1997; 23:845-848
41. Stern GA, Schemmer GB, Farber RD, Gorovoy MS. Effect of topical antibiotic solutions on corneal epithelial wound healing. Arch Ophthalmol 1983; 101:644-647
42. Bullard SR, O'Day DM. Pseudomembranous conjunctivitis following topical gentamicin therapy. Arch Ophthalmol 1997; 115:1591-1592
43. Fraunfelder FT, Bagby CC Jr, Kelly DJ. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 1982; 93:356-360
44. Collin HB, Carroll N. Ultrastructural changes to the corneal endothelium due to benzalkonium chloride. Acta Ophthalmol 1986; 64:226-231
45. Palmer RM, Kaufman HE. Tear film, pharmacology of eye drops, and toxicity. Curr Opin Ophthalmol 1995; 6(4):11-16
46. Tripathi BJ, Tripathi RC, Kolli SP. Cytotoxicity of ophthalmic preservatives on human corneal epithelium. Lens Eye Toxicity Res 1992; 9:361-375